Screener
Revolution Medicines, Inc. RVMD Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
FAQ
- What is Revolution Medicines, Inc.'s prepaid & other current?
- Revolution Medicines, Inc. (RVMD) reported prepaid & other current of $90.37M in Q2 2026.
- How has Revolution Medicines, Inc.'s prepaid & other current changed year-over-year?
- Revolution Medicines, Inc.'s prepaid & other current increased by 130.1% year-over-year, from $39.27M to $90.37M.
- What is the long-term trend for Revolution Medicines, Inc.'s prepaid & other current?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s prepaid & other current has grown at a 52.6% compound annual growth rate (CAGR), from $30.67M to $166.51M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Revolution Medicines, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude